These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 37445737)

  • 1. Expression-Based Diagnosis, Treatment Selection, and Drug Development for Breast Cancer.
    Ye Q; Wang J; Ducatman B; Raese RA; Rogers JL; Wan YW; Dong C; Padden L; Pugacheva EN; Qian Y; Guo NL
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of deregulated microRNAs in breast cancer progression using FFPE tissue.
    Chen L; Li Y; Fu Y; Peng J; Mo MH; Stamatakos M; Teal CB; Brem RF; Stojadinovic A; Grinkemeyer M; McCaffrey TA; Man YG; Fu SW
    PLoS One; 2013; 8(1):e54213. PubMed ID: 23372687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible Prognostic Role of HER2/Neu in Ductal Carcinoma In Situ and Atypical Ductal Proliferative Lesions of the Breast.
    Daoud SA; Ismail WM; Abdelhamid MS; Nabil TM; Daoud SA
    Asian Pac J Cancer Prev; 2016; 17(8):3733-6. PubMed ID: 27644608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD133 expressionand clinicopathologic significance in benign and malignant breast lesions.
    Liu TT; Li XF; Wang L; Yang JL
    Cancer Biomark; 2020; 28(3):293-299. PubMed ID: 32390595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter CpG island hypermethylation during breast cancer progression.
    Park SY; Kwon HJ; Lee HE; Ryu HS; Kim SW; Kim JH; Kim IA; Jung N; Cho NY; Kang GH
    Virchows Arch; 2011 Jan; 458(1):73-84. PubMed ID: 21120523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection and clinical significance of Notch1 methylation in breast cancer and intraductal proliferative breast lesions].
    Zhang N; Sun ZZ; Li F; Cao YW; Zhao CX; Liang WH; Sun HP; Li HA; Fu XG
    Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):324-9. PubMed ID: 21756827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression pattern and methylation of estrogen receptor α in breast intraductal proliferative lesions.
    Mao X; Qiao Z; Fan C; Guo A; Yu X; Jin F
    Oncol Rep; 2016 Oct; 36(4):1868-74. PubMed ID: 27498697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timing of critical genetic changes in human breast disease.
    Ellsworth RE; Ellsworth DL; Deyarmin B; Hoffman LR; Love B; Hooke JA; Shriver CD
    Ann Surg Oncol; 2005 Dec; 12(12):1054-60. PubMed ID: 16228814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape.
    Kader T; Hill P; Rakha EA; Campbell IG; Gorringe KL
    Breast Cancer Res; 2018 May; 20(1):39. PubMed ID: 29720211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical ductal hyperplasia is a multipotent precursor of breast carcinoma.
    Kader T; Hill P; Zethoven M; Goode DL; Elder K; Thio N; Doyle M; Semple T; Sufyan W; Byrne DJ; Pang JB; Murugasu A; Miligy IM; Green AR; Rakha EA; Fox SB; Mann GB; Campbell IG; Gorringe KL
    J Pathol; 2019 Jul; 248(3):326-338. PubMed ID: 30843206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical study of matrix metalloproteinase 9 and tissue inhibitor of matrix metalloproteinase 1 in benign and malignant breast tissue--strong expression in intraductal carcinomas of the breast.
    Rahko E; Kauppila S; Pääkkö P; Blanco G; Apaja-Sarkkinen M; Talvensaari-Mattila A; Turpeenniemi-Hujanen T; Jukkola A
    Tumour Biol; 2009; 30(5-6):257-64. PubMed ID: 19887890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of p53 protein in benign epithelial hyperplasia, atypical ductal hyperplasia, non-invasive and invasive mammary carcinoma: an immunohistochemical study.
    Umekita Y; Takasaki T; Yoshida H
    Virchows Arch; 1994; 424(5):491-4. PubMed ID: 7913368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
    Yang M; Xu SP; Ao QL
    Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active surveillance of women diagnosed with atypical ductal hyperplasia on core needle biopsy may spare many women potentially unnecessary surgery, but at the risk of undertreatment for a minority: 10-year surgical outcomes of 114 consecutive cases from a single center.
    Farshid G; Edwards S; Kollias J; Gill PG
    Mod Pathol; 2018 Mar; 31(3):395-405. PubMed ID: 29099502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aromatase expression in atypical ductal hyperplasia in women.
    Santen RJ; Radisky DC; Degnim A; Frost MH; Vachon CM; Ghosh K; Guestini F; McNamara KM; Sasano H
    Breast Cancer Res Treat; 2017 Jun; 163(3):623-629. PubMed ID: 28337664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Utility of SOX10 Immunohistochemical Staining in Breast Pathology.
    Rammal R; Goel K; Elishaev E; Rinda Soong T; Jones MW; Zhao C; Clark BZ; Carter GJ; Yu J; Fine JL; Villatoro TM; Harinath L; Bhargava R
    Am J Clin Pathol; 2022 Nov; 158(5):616-625. PubMed ID: 36000970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type of Architecture, Presence of Punctate Necrosis, and Extent of Involvement in Atypical Ductal Hyperplasia Can Predict the Diagnosis of Breast Carcinoma on Excision: A Clinicopathologic Study of 143 Cases.
    Zhang C; Wang EY; Liu F; Ruhul Quddus M; James Sung C
    Int J Surg Pathol; 2021 Oct; 29(7):716-721. PubMed ID: 33881947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
    Xu R; Perle MA; Inghirami G; Chan W; Delgado Y; Feiner H
    Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical ductal hyperplasia bordering on DCIS on core biopsy is associated with higher risk of upgrade than conventional atypical ductal hyperplasia.
    Pawloski KR; Christian N; Knezevic A; Wen HY; Van Zee KJ; Morrow M; Tadros AB
    Breast Cancer Res Treat; 2020 Dec; 184(3):873-880. PubMed ID: 32857242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences and Relationships Between Normal and Atypical Ductal Hyperplasia, Ductal Carcinoma In Situ, and Invasive Ductal Carcinoma Tissues in the Breast Based on Raman Spectroscopy.
    Han B; Du Y; Fu T; Fan Z; Xu S; Hu C; Bi L; Gao T; Zhang H; Xu W
    Appl Spectrosc; 2017 Feb; 71(2):300-307. PubMed ID: 28181469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.